Serum albumin predicts survival in patients with hilar cholangiocarcinoma

Background and aims: Hilar cholangiocarcinoma is a devastating malignancy with incidence varying by geography and other risk factors. Rapid progression of disease and delays in diagnosis restrict the number of patients eligible for curative therapy. The objective of this study was to determine progn...

Descripción completa

Detalles Bibliográficos
Autores principales: Waghray, Abhijeet, Sobotka, Anastasia, Marrero, Carlos Romero, Estfan, Bassam, Aucejo, Federico, Narayanan Menon, KV
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2017
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5444265/
https://www.ncbi.nlm.nih.gov/pubmed/27389416
http://dx.doi.org/10.1093/gastro/gow021

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5444265/
https://www.ncbi.nlm.nih.gov/pubmed/27389416
http://dx.doi.org/10.1093/gastro/gow021

Ejemplares similares